CIK 0001708599 · Non-accelerated filer<br>Smaller reporting company
Serina Therapeutics, Inc.
Sign in to watch- Ticker
- SER
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- AL
- Entity type
- operating
- EIN
- 821436829
- Phone
- (256) 327-9630
- Business address
- 601 GENOME WAY, SUITE 2001, HUNTSVILLE, AL, 35806
- Former names
- AgeX Therapeutics, Inc.
- 4 Open-market buy Director bought 19,200 shares at an average $7.30 ($140,116)
- 4 Open-market buy Director bought 8,943 shares at $6.59 ($58,928)
- 4 Open-market buy Director bought 6,400 shares at $7.07 ($45,228)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 7,600 shares at an average $9.33 ($70,900)
- 4 Open-market buy Director bought 6,378 shares at $9.50 ($60,591)
- 4 Open-market buy Director bought 9,019 shares at $9.50 ($85,681)
- 4 Open-market buy Director bought 3,287 shares at $9.50 ($31,227)
- 4 Open-market buy Director bought 12,380 shares at an average $9.76 ($120,827)
- 4 Open-market buy Director bought 1,422 shares at $9.50 ($13,509)
- 4 Open-market buy Director bought 100 shares at $9.00 ($900)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
Page 5 of 9 · 177 filings